Inari Medical Price to Book Ratio 2019-2024 | NARI
Historical price to book ratio values for Inari Medical (NARI) over the last 10 years. The current price to book ratio for Inari Medical as of November 07, 2024 is 6.98.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Inari Medical Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-11-06 | 53.27 | 7.16 | |
| 2024-09-30 | 41.24 | $7.44 | 5.54 |
| 2024-06-30 | 48.15 | $7.29 | 6.61 |
| 2024-03-31 | 47.98 | $7.71 | 6.22 |
| 2023-12-31 | 64.92 | $8.05 | 8.07 |
| 2023-09-30 | 65.40 | $7.86 | 8.32 |
| 2023-06-30 | 58.14 | $7.61 | 7.64 |
| 2023-03-31 | 61.74 | $7.48 | 8.26 |
| 2022-12-31 | 63.56 | $7.72 | 8.23 |
| 2022-09-30 | 72.64 | $7.75 | 9.38 |
| 2022-06-30 | 67.99 | $7.76 | 8.76 |
| 2022-03-31 | 90.64 | $7.90 | 11.48 |
| 2021-12-31 | 91.27 | $4.75 | 19.20 |
| 2021-09-30 | 81.10 | $4.67 | 17.35 |
| 2021-06-30 | 93.28 | $4.45 | 20.95 |
| 2021-03-31 | 107.00 | $4.31 | 24.84 |
| 2020-12-31 | 87.29 | $4.07 | 21.47 |
| 2020-09-30 | 69.02 | $3.94 | 17.54 |
| 2020-06-30 | 48.44 | $3.80 | 12.74 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $3.035B | $0.494B |
| Inari Medical, Inc. is a commercial-stage medical device company committed toward developing products to treat and change the lives of patients suffering from venous diseases. Its initial product offering comprises 2 minimally-invasive, novel catheter-based mechanical thrombectomy devices. It built its products purposely on the basis of the specific characteristics of the venous system and the treatment of the two distinct indications of venous thromboembolism or VTE (deep vein thrombosis and pulmonary embolism/ PE). Its FlowTriever product is the first thrombectomy system, which is FDA-cleared, used for the treatment of PE. Its advanced systems & processes to control the key relationships between its sales representatives and treating physicians like cardiologists, radiologists, helps it to quickly iterate products, launch and execute physician education and training programs and scale its sales organization. The company markets and sells its products to hospitals across the U.S. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $212.628B | 25.94 |
| Intuitive Surgical (ISRG) | United States | $186.738B | 97.63 |
| Alcon (ALC) | Switzerland | $45.674B | 32.15 |
| IQVIA Holdings (IQV) | United States | $39.509B | 21.77 |
| Edwards Lifesciences (EW) | United States | $38.832B | 24.66 |
| IDEXX Laboratories (IDXX) | United States | $35.456B | 41.76 |
| DexCom (DXCM) | United States | $26.916B | 40.53 |
| Waters (WAT) | United States | $22.926B | 33.90 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.977B | 0.00 |
| STERIS (STE) | Ireland | $21.252B | 24.49 |
| Hologic (HOLX) | United States | $18.417B | 19.43 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.517B | 12.85 |
| Sysmex ADR (SSMXY) | Japan | $12.405B | 38.90 |
| Globus Medical (GMED) | United States | $11.099B | 28.27 |
| Teleflex (TFX) | United States | $9.197B | 14.67 |
| Penumbra (PEN) | United States | $8.945B | 87.62 |
| Masimo (MASI) | United States | $8.639B | 41.80 |
| Glaukos (GKOS) | United States | $7.682B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.022B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.514B | 25.59 |
| TransMedics (TMDX) | United States | $2.870B | 90.96 |
| Veracyte (VCYT) | United States | $2.868B | 86.84 |
| LivaNova (LIVN) | United Kingdom | $2.823B | 16.30 |
| Nihon Kohden (NHNKY) | Japan | $2.488B | 18.90 |
| Elekta AB (EKTAY) | Sweden | $2.336B | 19.03 |
| Tandem Diabetes Care (TNDM) | United States | $2.188B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.968B | 10.29 |
| RxSight (RXST) | United States | $1.881B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.334B | 0.00 |
| Artivion (AORT) | United States | $1.214B | 80.50 |
| Pulse Biosciences (PLSE) | United States | $1.106B | 0.00 |
| OPKO Health (OPK) | United States | $1.011B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.939B | 15.96 |
| IRadimed (IRMD) | United States | $0.707B | 38.23 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.696B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.668B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.666B | 0.00 |
| SiBone (SIBN) | United States | $0.649B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.638B | 15.10 |
| Paragon 28 (FNA) | United States | $0.591B | 0.00 |
| AxoGen (AXGN) | United States | $0.582B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.492B | 0.00 |
| CVRx (CVRX) | United States | $0.377B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.370B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.366B | 19.81 |
| Delcath Systems (DCTH) | United States | $0.304B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.291B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.276B | 18.50 |
| Sight Sciences (SGHT) | United States | $0.235B | 0.00 |
| Inogen (INGN) | United States | $0.224B | 0.00 |
| NeuroPace (NPCE) | United States | $0.221B | 0.00 |
| Accuray (ARAY) | United States | $0.210B | 0.00 |
| Nevro (NVRO) | United States | $0.199B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.189B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.156B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.129B | 0.00 |
| 908 Devices (MASS) | United States | $0.126B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.114B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.107B | 15.95 |
| EDAP TMS S.A (EDAP) | France | $0.101B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.090B | 0.00 |
| LENSAR (LNSR) | United States | $0.080B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.079B | 0.00 |
| Hyperfine (HYPR) | United States | $0.070B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | Israel | $0.059B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.054B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.047B | 0.00 |
| Envoy Medical (COCH) | United States | $0.040B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Neuronetics (STIM) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.029B | 0.00 |
| Precision Optics (POCI) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.025B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.014B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |